The UK medicines regulator, the MHRA, issues a warning to stop selling a batch of lercanidipine blood pressure tablets. The regulator says the affected supply could be associated with side-effects and tells health professionals not to sell that specific batch.
Both outlets frame the notice as an immediate health alert, highlighting that the action involves a recall and a “stop” order affecting one batch. The Mirror focuses on the regulator’s instruction to stop selling the batch and the potential for side-effects. The Daily Record (Scotland) similarly reports an “immediate” alert, adding that the batch has been recalled following a reported “mix-up,” while also pointing to the risk of possible side-effects.